Speakers

Daniel Fritz, PharmaLedger Association, Switzerland
Executive Director. More than 30 years of leadership and supply chain IT experience in the US Army, financial, and pharmaceutical industries

Dr Rainer Gnibl, Government of Upper Bavaria, Germany
GMP Inspector for the District Government and the EMA, Advisory Board member of EQPA

Alexander Kammerlocher, Local Competent Authority Baden-Württemberg, Germany
GMP Inspector

Mag.pharm. Andreas Kraßnigg, Austrian Agency for Health and Food Safety (AGES), Austria
Head Pharmaceutical Inspections and Member of Annex 16 Drafting Group, Chair of the PIC/S Sub-Committee on Expert Circles and Advisory Board member of EQPA

Anna Maria Kurzreiter, Austrian Agency for Health and Food Safety (AGES), Austria
Inspector and Senior Expert

Dr Marianne Lunzer, Austrian Agency for Health and Food Safety (AGES), Austria
Safety Assessor, Department Clinical Trials and Clinical Trials Coordination Group (CTCG) Chair

Gillian Renouf, Royal Pharmaceutical Society QP Assessment Panel, U.K.
Chair of the RPS QP Assessment Panel

Alexandra Bauloye, GlaxoSmithKline, Belgium
Risk Management and Governance Lead, GSK Corporate

Cheryl Chia, Lotus Phoenix Consulting, Netherlands
Consultant for GMP and GDP compliance in the pharmaceutical supply chain

David Cockburn, European Qualified Person Association (EQPA)
Member of the EQPA Board of Directors. Former Chair of the EMA GMP/GDP IWG

Dr Carsten Coors, Vetter Development Services Austria
Qualified Person

Jan Dillingh, Fagron, Netherlands
Qualified Person and Managing Pharmacist at the Fagron Sterile Preparation Pharmacy

Dr Susanne Ding, Boehringer Ingelheim, Germany
Qualified Person for Investigational Medicinal Products and member of the EQPA Board of Directors

Walid El Azab, Steris, Belgium
Qualifi ed Person and Technical Services Senior Manager, Life Sciences Division, leader of the ECA CCS Task Force

Georg Göstl, Takeda, Austria
Qualified Person, Chair of the Austrian QP Association aqpa and member of the EQPA Board of Directors.

Tor Gråberg, AstraZeneca, Sweden
Head of External Advocacy, Global Quality, Operations, and member of the EQPA Board of Directors. Former Head of the Drug Inspectorate at the Swedish Medical Products Agency and former PIC/S Chair

Energy Kristina Hansen, Ferring, Denmark
Certified quality auditor and consultant with her own company MilCor Consulting

Katrien Himpens, Janssen, Belgium
Qualified Person IMP, Senior Director QA Clinical Supply Chain

Dr Afshin Hosseiny, Tabriz Consulting, U.K.
Managing Director and Qualified Person, Chair of the ECA Executive Board and Chair of the European GDP Association

Dr Monika Hupfauf, Koch/Hupfauf Attorneys-at Law, Austria
Lawyer with focus on the development of pharmaceuticals and medical products up to and including market entry

Patryk Jegorow, Takeda, Ireland
Qualified Person and Head of Quality Compliance and Systems Biologics Operating Unit, Member of the IMP Working Group within the EQPA

Dr Ulrich Kissel, KisselPharma Consulting, Germany
Qualified Person and Chairman of the EQPA Board of Directors

Aidan Madden, FivePharma, Ireland
CEO

Sue Mann, Sue Mann Consultancy Ltd. U.K.
Qualified Person and QP Assessor working on behalf of the MHRA, representing the Royal Pharmaceutical Society

Dr Frank Seibel, Roche Diagnostics, Germany
Quality Site Head

Dr Joerg Stüben, Boehringer Ingelheim International, Germany
Head of Regulatory Information Management and Senior Expert

Prof Dr Ramzan Tabasum, Lonza, Switzerland
Senior Director and Visiting Professor SBS Swiss Business School